A double-blind, randomized, placebo-controlled study assessing the efficacy and tolerability of desvenlafaxine 10 and 50 mg/day in adult outpatients with major depressive disorder

BACKGROUND: In an effort to establish the lowest effective dose of desvenlafaxine (administered as desvenlafaxine succinate), we assessed the efficacy, safety, and tolerability of 10- and 50-mg/day desvenlafaxine vs placebo for the treatment of major depressive disorder. METHODS: Adult outpatients w...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Liebowitz, Michael R, Tourian, Karen A, Hwang, Eunhee, Mele, Linda
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2013
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3763843/
https://ncbi.nlm.nih.gov/pubmed/23517291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-244X-13-94
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky